In business as in medicine, a remedy can take time to kick in. This is the challenge for Chinese drug giant CSPC Pharmaceutical Group Ltd. (1093.HK), which is trying to transform itself from being a ...
The Board of Directors of CSPC Pharmaceutical Group recently announced that its novel SYH2070 siRNA injection received regulatory approval to begin clinical trials in both the U.S. and China for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results